Abstract:Background In many aspects Behcet9s disease (BD) is correlated with tuberculosis (TB). They may mimic each other on clinical manifestations. For example erythema nodosa, arthritis, gut lesions could be occurred in both disease and it is difficult for differential diagnosis. Some patients with newly-diagnosed BD were found to have active or latent or old TB and anti-TB therapy could relieve some of the symptoms. In etiology, it has been postulated that tubercle bacilli may act as a trigger of BD through the mechanism of molecular mimicking. Vice versa, defective cell-mediated immunity in BD patients may increase individual susceptibility of TB.It is extremely important to clarify TB existence or not in BD patients. Since BD patients commonly need glucocorticoid and immunosuppressant or even biologic agent such as anti-TNFa. And these medications may increase the risk of occurrence or flare of TB. But positive result of PPD shows little value in this special population due to acupuncture reaction in BD patients.In this pilot study, the values of interferon-γ release assay (T-SPOT-TB) in diagnosing active TB in BD patients were explored. Objectives To investigate the diagnostic value of the T-SPOT.TB in BD patients complicated with tuberculosis infection. Methods The clinical, radiology and laboratory data were collected and analyzed in 175 hospitalized BD patients from the Peking Union Medical College Hospital between January 2010 and March 2015. Statistical analysis was carried out using IBM SPSS version 20. Results Of the 175 BD patients, the positive rate of tuberculosis infection in BD patients was 34.3%. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the T-SPOT.TB test for the diagnosis of ATB were 87.5%, 73%, 36.8%, 98.3%, respectively. Positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were 3.24 and 0.17. The median number of SFCs in the BD-ATB group was higher than that in the BD-LTB group and BD-OTB (p<0.001 and p=0.012). By ROC method, it was suggested that 70 SFCs act as a cutoff for diagnosing BD-ATB with the sensitivity, specificity, PPV, NPV, PLR and NLR were 87.5%, 85%, 24.6%, 98.5%, 5.79 and 0.15, respectively. The rates of LTB infection had no significant difference between BD patients and healthy controls. Agreement between T-SPOT.TB and TST in BD patients measured by the kappa coefficient was poor (kappa =0.37).Multiple logistic regression analysis revealed that BD patients with positive T-SPOT.TB had the highest likelihood of ATB (OR 11.93, 95% CI 2.108–67.508, p=0.005). Conclusions T-SPOT.TB is a promising test in the diagnosis of BD complicated with tuberculosis infection, and higher number of SFCs may has a higher risk of ATB. Disclosure of Interest None declared

Utility of in vitro interferon-γ release assay in differential diagnosis between intestinal tuberculosis and Crohn's disease.

Differentiating Crohnʼs Disease from Intestinal Tuberculosis Using an Interferon Gamma Release Assay

Levels of TB-IGRA May Help to Differentiate Between Intestinal Tuberculosis and Crohn’s Disease in Patients with Positive Results

Application value of tissue tuberculosis antigen combined with Xpert MTB/RIF detection in differential diagnoses of intestinal tuberculosis and Crohn’s disease

Value of Polymerase Chain Reaction for Mycobacterium Tuberculosis Differential Diagnosis of Intestinal Tuberculosis and Crohn's Disease

Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians.

Differences in clinical features of Crohn's disease and intestinal tuberculosis.

Clinical Features, Differential Diagnosis and Intestinal Mucosal TB-PCR for Intestinal Tuberculosis and Crohn's Disease

Assessment of Interferon-Gamma Release Assay in Patients with Non-Tuberculous Mycobacteria Pulmonary Disease

Clinical and Endoscopic Analysis of Crohn's Disease and Intestinal Tuberculosis

The primary study of T-SPOT.TB assay in the diagnosis of intestinal tuberculosis

Differential Diagnosis Between Crohn's Disease and Intestinal Tuberculosis in China

The In-Vitro Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis and Mycobacterium Tuberculosis Infections

AB0596 Interferon-Γ Release Assay (T-SPOT.TB) in the Diagnosis of Tuberculosis Infection in Patients with Behcet's Disease: a Single Center Experience in China

Application of T-SPOT.TB in connective tissue disease combined with tuberculosis

Feasibility of polymerase chain reaction for detecting Mycobacterium tuberculosis DNA in differential diagnosis of intestinal tuberculosis and Crohn disease

Evaluation Of Interferon-Gamma Release Assay (T-Spot.Tb (Tm)) For Diagnosis Of Tuberculosis Infection In Rheumatic Disease Patients

Clinical Application of T-SPOT.TB in Diagnosis of HIV/AIDS and TB Patients

The value of empiric anti-tuberculosis therapy in the differential diagnosis between intestinal tuberculosis and Crohn ’ s disease in China

Interferon-Gamma Release Assay Performance In Pulmonary And Extrapulmonary Tuberculosis

CHnical and Endoscopic Evaluation of Anti-Tuberculosis Trial for Differentiation Between Intestinal Tuberculosis and Crohn＇s Disease